Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2022-01-18 00:00:00 ET · period of report 2022-01-13 · accession 0001891257-22-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-01-18 | 2022-01-13+ | LSTA | Girolamo Todd C | CLO, SVP of Corp Dev | F - Tax | $0.8146 | -4,721 | 160.8K | -3% | -$3,846 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-13 | F | D | 2,563 | $0.81 | 162,985 | D | — | — | (F1) Shares withheld as payment of a tax liability on vesting of restricted stock. (F2) Includes 123,000 unvested restricted stock. |
| 2 | Common | Common Stock | 2022-01-14 | F | D | 2,158 | $0.82 | 160,827 | D | — | — | (F1) Shares withheld as payment of a tax liability on vesting of restricted stock. (F3) Includes 119,000 unvested restricted stock. |